EYPT

NASD EyePoint Pharmaceuticals, Inc.
Oct 12, 2026 · 9:53 PM ET EOD Market Closed

$3.32 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.32, $0.11 below the day’s high of $3.43

YTD change
-81.83%
vs 20-day SMA
-6.82%
vs 200-day SMA
-72.75%

Price ranges

Previous day
$3.38 $3.57
open $3.44 close $3.40
-$0.04 (-1.16%)
Today
$3.29 $3.43
open $3.42 now $3.32
-$0.10 (-2.92%)
Past week
$3.05 $3.57
from $3.25 now $3.32
+$0.07 (+2.15%)
Past month
$3.05 $4.34
from $4.23 now $3.32
-$0.91 (-21.51%)
This year
$3.05 $18.87
from $18.27 now $3.32
-$14.95 (-81.83%)

Price & Performance

-11.20 (-77.13%) / 6M

$2.20$6.81$11.41$16.02Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.3% away from all-time highs of $121.40
  • EYPT is down 82% since the beginning of the year
  • EYPT is down 76% over the past 12 months
  • EYPT is down 22% over the past 1 month

EYPT reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -75.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.85
Earnings momentum -10.5% Quarterly EPS growth
Quarterly change -10.5%

Valuation

P/E ratio N/A
Enterprise value $593.3M
Beta 2.06

Balance sheet & scale

IncomeN/A
Revenue$51.9M
Cash$255.7M
Debt$21.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $286.2M

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,182.62 +0.28%
JNJ Johnson & Johnson $263.73 +0.88%
ABBV AbbVie, Inc. $281.12 +1.68%
AZN AstraZeneca PLC Sponsored ADR $158.33 -0.55%
MRK Merck & Co., Inc. $145.45 -0.10%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.